Patents by Inventor Tarek Aboul-Fadl Mohamed Hassan

Tarek Aboul-Fadl Mohamed Hassan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8552026
    Abstract: The present invention relates to an isatin derivative having the formula (I), a medicament for treatment of tuberculoses containing that isatin derivative as well as a method for preparing isatin derivative according to formula (I).
    Type: Grant
    Filed: April 7, 2011
    Date of Patent: October 8, 2013
    Assignee: King Saud University
    Inventors: Tarek Aboul-Fadl Mohamed Hassan, Fayzah bint Ahmad S. Bin Jubair
  • Patent number: 8497296
    Abstract: The invention is directed to a compound of Formula (I), wherein R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; X is selected from the group consisting of hydrogen atom or halogen atom; and Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group, as well as for its use in therapy, preferably for the treatment of cancer, and to a related pharmaceutical composition, the use of the compound for the manufacture of a medicament for the respective medical indication, and a method of synthesis of the compounds of the invention.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: July 30, 2013
    Assignee: King Saud University
    Inventors: Tarek Aboul-Fadl Mohamed Hassan, Adnan Ahmed Kadi, Hatem Abdel-Khader Abdel-Aziz
  • Publication number: 20120259119
    Abstract: The present invention relates to an isatin derivative having the formula (I), a medicament for treatment of tuberculoses containing that isatin derivative as well as a method for preparing isatin derivative according to formula (I).
    Type: Application
    Filed: April 7, 2011
    Publication date: October 11, 2012
    Inventors: Tarek Aboul-Fadl Mohamed Hassan, Fayzah bint Ahmad S. Bin Jubair
  • Publication number: 20120252860
    Abstract: The invention is directed to a compound of Formula (I), wherein R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; X is selected from the group consisting of hydrogen atom or halogen atom; and Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group, as well as for its use in therapy, preferably for the treatment of cancer, and to a related pharmaceutical composition, the use of the compound for the manufacture of a medicament for the respective medical indication, and a method of synthesis of the compounds of the invention.
    Type: Application
    Filed: March 16, 2012
    Publication date: October 4, 2012
    Applicant: King Saud University
    Inventors: Tarek Aboul-Fadl Mohamed Hassan, Adnan Ahmed Kadi, Hatem Abdel-Khader Abdel-Aziz